article thumbnail

Getting at the Heart of Leadership

You're Not the Boss of Me

I wrote this post in September, 2011. And, if we expect them to bring all of themselves to work and dedicate their energies to the success of our enterprises, we must also care about them. Ms Ingraham worked as an Administrative Assistant for a pharmaceutical company in New Jersey. There are lessons here worth repeating. .

article thumbnail

Why America Is Losing Its Entrepreneurial Edge

Harvard Business Review

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What's Next For Guangdong?

Harvard Business Review

While Guangdong's exports accounted for as much as 37% of China's exports by 2000, its share dropped to 28% in 2011. The province's exports growth rate, which was 26% in 2010, fell to 22% in the first nine months of 2011, and it has continued to decline ever since. Look at the data.

article thumbnail

How to Know If a Spin-Off Will Succeed

Harvard Business Review

The diverging fortunes of two recent spin-offs in the energy industry illustrate how financial markets value autonomy from the parent. We are not saying that rapid ownership change is a requirement for business success—quite to the contrary, it is often a corollary.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. In battery research, for example, scientists have long focused on finding materials with greater energy density.

article thumbnail

India Remakes Global Innovation

Harvard Business Review

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.

article thumbnail

The 2010 Execution Round-Up: Six Companies That Couldn't 'Get It.

Strategy Driven

It’s what I push my clients to focus on as they seek to improve organizational performance – and it’s the lens I urge all leaders to look through as they review 2010 and make their ‘business resolutions’ for 2011. Here are a few of this year’s headline makers and the lessons that can be learned from each of them.